Insys to Pay $225 Million to Settle Opioid-Sales Probe - Claims Jour...

06/07/19

Insys to Pay $225 Million to Settle Opioid-Sales Probe  Claims Journal

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle ...

[more]